NPI: 1316901457 · MARTINSVILLE, VA 24112 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,418 | $359K |
| 2019 | 33,441 | $387K |
| 2020 | 26,076 | $453K |
| 2021 | 28,784 | $408K |
| 2022 | 21,835 | $332K |
| 2023 | 14,112 | $303K |
| 2024 | 2,580 | $56K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 53,654 | 3,281 | $2.16M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 49,384 | 2,318 | $95K |
| J1756 | Injection, iron sucrose, 1 mg | 12,428 | 1,986 | $16K |
| A4657 | Syringe, with or without needle, each | 9,024 | 2,239 | $14K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 85 | 42 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,758 | 1,453 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,062 | 590 | $764.80 |
| 83970 | 2,563 | 1,414 | $439.85 | |
| J0636 | Injection, calcitriol, 0.1 mcg | 532 | 39 | $354.07 |
| 90674 | 111 | 81 | $324.03 | |
| 90747 | 24 | 13 | $278.96 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 253 | 51 | $212.62 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 312 | 162 | $209.53 |
| 82728 | 1,796 | 981 | $139.36 | |
| 83540 | 1,951 | 1,084 | $93.87 | |
| 83550 | 1,905 | 1,057 | $87.55 | |
| G0008 | Administration of influenza virus vaccine | 170 | 112 | $81.76 |
| 85041 | 2,779 | 1,591 | $52.71 | |
| 85048 | 2,777 | 1,590 | $43.81 | |
| 0124A | 22 | 17 | $7.92 | |
| 82108 | 303 | 171 | $5.69 | |
| 0011A | 19 | 14 | $2.96 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 334 | 52 | $0.00 |